Is Piperlonguminine safe in cosmetics?
Piperlonguminine has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
Also known as: N-Isobutylpiperamide, 2,4-Pentadienamide, 5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (E,E)-, 2,4-Pentadienamide, 5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E,4E)-
INCI: PIPERLONGUMININE
Piperlonguminine (CAS 5950-12-9) is a cosmetic cosmetic ingredient functioning as Skin conditioning; anti-inflammatory alkaloid amide. EU Regulation 1223/2009 status: permitted. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in pharmaceutical data.
View industrial chemical safety profile for CAS 5950-12-9 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Piperlonguminine.
Calculate MoS for your specific formulation with the MoS Calculator.
Expert safety assessment and concern-level summary for Piperlonguminine.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Piperlonguminine has a safety rating of "MODERATE" in our database. EU status: permitted. US status: permitted.
Piperlonguminine EU regulatory status: permitted. This is based on EU Regulation 1223/2009 and its amendments.
Piperlonguminine functions as: Skin conditioning; anti-inflammatory alkaloid amide. It is classified as a cosmetic ingredient in our database. CAS number: 5950-12-9.
Piperlonguminine also appears in pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Piperlonguminine compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Piperlonguminine in your formulation.